Remove 2023 Remove Asthma Remove Management Remove Specialization
article thumbnail

Texas invests $50M in psychedelic drug research to treat addiction

Medical Xpress

Ibogaine shows potential for promoting neuroplasticity and aiding recovery, though it carries cardiac risks that require careful management. The initiative aims to attract additional private investment and facilitate FDA approval. This summary was automatically generated using LLM.

article thumbnail

An Arm and a Leg: The Prescription Drug Playbook, Part I

Physician's Weekly

About 3 in 10 adults reported not taking their medicines as prescribed at some point between July 2022 and July 2023 because of the cost, according to a KFF survey. In January of last year, Cole went to a Walgreens in Appleton, Wisconsin, to get refills on the medication he used to control his asthma. He left without it. Dan: I KNOW!